Cor Vasa 2011, 53(8-9):439-443 | DOI: 10.33678/cor.2011.111
Secondary forms of hypertension, classification and common causes
- Centrum pro výzkum, diagnostiku a léčbu arteriální hypertenze, III. interní klinika, Všeobecná fakultní nemocnice a 1. lékařská fakulta Univerzity Karlovy, Praha, Česká republika
Secondary hypertension occurs in 5-10% of patients with arterial hypertension. The most common causes are endocrine - particularly primary aldosteronism, renal (renal parenchymal and renovascular) hypertension, sleep apnea syndrome and hypertension in pregnancy. Patients with secondary hypertension often have very high blood pressure. With regard to the possibility of permanent cure / improved control of hypertension, it is useful for patients with suspected secondary form of hypertension to be examined in a specialized centre.
Keywords: Secondary hypertension; Endocrine hypertension; Renal hypertension; Sleep apnea syndrome; Hypertension in pregnancy
Published: August 1, 2011 Show citation
References
- Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-223.
Go to original source...
- Widimský J. Hypertenze. 3. vyd. Praha: Triton, 2008.
- Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC Practice Guidelines for the management of arterial hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007;25:1751-1762.
Go to original source...
Go to PubMed...
- Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens 2001;14:1263-1269.
Go to original source...
- Hermida RC, Ayala DE, Calvo C, et al. Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension. Hypertension 2005;46:1053-1059.
Go to original source...
Go to PubMed...
- Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008;117:e510-526.
Go to original source...
- Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 2007;66:607-618.
Go to original source...
Go to PubMed...
- Štrauch B, Zelinka T, Hampf M, et al. Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. J Hum Hypertens 2003;17:349-352.
Go to original source...
Go to PubMed...
- Milliez P, Girerd X, Plouin P, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005;45:1243-1248.
Go to original source...
Go to PubMed...
- Rossi GP, Bernini G, Desideri G, et al. Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 2006;48:232-238.
Go to original source...
Go to PubMed...
- Tanabe A, Naruse M, Naruse K, et al. Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens Res 1997;20:85-90.
Go to original source...
Go to PubMed...
- Fallo F, Veglio F, Bertello C, et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 2006;91:454-459.
Go to original source...
Go to PubMed...
- Strauch B, Petrák O, Wichterle D, et al. Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension. Am J Hypertens 2006;19:909-914.
Go to original source...
Go to PubMed...
- Holaj R, Zelinka T, Wichterle D, et al. Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension. J Hypertens 2007;25:1451-1457.
Go to original source...
Go to PubMed...
- Young WF Jr, Klee GG. Primary aldosteronism. Diagnostic evaluation. Endocrinol Metab Clin North Am 1988;17:367-395.
Go to original source...
Go to PubMed...
- Widimský J. Sekundární hypertenze. Praha: Triton, 2003.
- Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008;93:3266-3281.
Go to original source...
Go to PubMed...
- Celen O, O'Brien MJ, Melby JC, Beazley RM. Factors influencing outcome of surgery for primary aldosteronism. Arch Surg 1996;131:646-650.
Go to original source...
Go to PubMed...
- Lumachi F, Ermani M, Basso SMM, et al. Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: Multivariate analysis of factors affecting unresolved hypertension and review of the literature. Am Surg 2005;71:864-869.
Go to original source...
Go to PubMed...
- Monhart V. Hypertenze a ledviny. Praha: Triton, 2004.
- Buckalew VM Jr, Berg RL, Wang SR, et al. Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis 1996;28:811-821.
Go to original source...
- Conlon PJ, O'Riordan E, Kalra PA. New insights into the epidemiologic and clinical manifestations of atherosclerotic renovascular disease. Am J Kidney Dis 2000;35:573-587.
Go to original source...
Go to PubMed...
- Aqel RA, Zoghbi GJ, Baldwin SA, et al. Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization. J Hypertens 2003; 21:1157-1162.
Go to original source...
- Hackam DG, Spence JD, Garg AX, Textor SC. Role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertension. Hypertension 2007;50:998-1003.
Go to original source...
Go to PubMed...
- Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008;118:1080-1111.
Go to original source...
- Parati G, European Cost Action B26; European Society of Hypertension; European Respiratory Society. Consensus document on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Cost Action B26, the European Society of Hypertension and the. Salerno: Momento Medico; 2010.
- Lavie L, Hefetz A, Luboshitzky R, Lavie P. Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment. J Mol Neurosci 2003;21:57-63.
Go to original source...
Go to PubMed...
- Duchna H-W, Orth M, Schultze-Werninghaus G, et al. Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome. Sleep Breath 2005;9:97-103.
Go to original source...
Go to PubMed...